Status:

WITHDRAWN

Colonisation Resistance Study

Lead Sponsor:

Danone Asia Pacific Holdings Pte, Ltd.

Collaborating Sponsors:

Danone Global Research & Innovation Center

Conditions:

Healthy Infants

Eligibility:

All Genders

8-10 years

Phase:

PHASE2

Brief Summary

This study is initiated to investigate the effect of infant formulas with added specific prebiotic oligosaccharides on the reduction of specific potential pathogens and/or toxins.

Eligibility Criteria

Inclusion

  • Healthy term infants (gestational age 37 to 42 weeks) aged 2-2.5 months at inclusion
  • Fully formula fed for at least one week (not applicable for the breastfeeding reference group since these infants must be exclusively breastfed before and throughout the study)
  • Parents' or guardian's written informed consent

Exclusion

  • Being weaned before inclusion (introduction of any other foods other than formula or breast milk.)
  • Moderate or severe acute malnutrition, defined as weight-for-age and sex below -2 z-scores of the median WHO growth standards
  • Disorders requiring a special diet (such as food intolerance or food allergy or complaints such as reflux, constipation and cramps)
  • Significant congenital abnormality that could affect the study results
  • Use of systemic antibiotics or anti-mycotic drugs in the 4 weeks preceding the study
  • Investigator's uncertainty about the willingness or ability of the parents to comply with the protocol requirements
  • Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study
  • Gastroenteritis in the last two weeks before inclusion

Key Trial Info

Start Date :

January 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2012

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01507935

Start Date

January 1 2012

End Date

November 1 2012

Last Update

September 5 2012

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

King Chulalongkorn Memorial Hospital

Bangkok, Thailand

2

Phramongkutklao Hospital

Bangkok, Thailand